NanoVelcro Cell Technology Applied in Diagnosis of Pregnancy Complications
By LabMedica International staff writers Posted on 02 Sep 2021 |

Image: The NanoVelcro device has been used to detect placenta accreta spectrum (PAS) disorders (Photo courtesy of University of California, Los Angeles)
Placenta accreta spectrum (PAS) disorders, including placenta accreta, placenta increta, and placenta percreta, are the consequences of abnormal implantation, or aberrant invasion and adherence of placental trophoblasts into the uterine myometrium.
Current diagnostic modalities for PAS, including serum analytes, ultrasonography, and magnetic resonance imaging (MRI), are effective but not always conclusive, and some options are not readily available in low resource settings. Circulating trophoblast cell clusters can be used for early detection of PAS disorders.
Medical Scientists at the University of California, Los Angeles (UCLA, Los Angeles, CA, USA) and their colleagues included in a study pregnant women aged from 18 to 45 years old with singleton intrauterine pregnancies, and gestational age (GA) between 6 and 40 weeks. The team analyzed blood samples from 168 pregnant individuals, divided between those with clinically confirmed PAS, placenta previa, or normal placentation and an additional 15 healthy non-pregnant female donors served as controls.
The investigators used the a cell isolation technology called NanoVelcro Chip developed by UCLA. NanoVelcro is a nanostructure-embedded microchip designed to capture and enrich specific target cells from a mixed sample. The samples were run through NanoVelcro Chips under optimized conditions and immunostained and were imaged using the Nikon Ni fluorescence microscope (Melville, NY, USA). Trophoblast-specific gene expression in placenta tissue was performed to validate the selected trophoblast-specific gene panel.
The team discovered a uniquely high prevalence of clustered circulating trophoblasts (cTB-clusters) in PAS and subsequently optimized the device to preserve the intactness of these clusters. The feasibility study on the enumeration of cTBs and cTB-clusters from 168 pregnant women demonstrates excellent diagnostic performance for distinguishing PAS from non-PAS. The combined cTB assay achieves an Area Under ROC Curve of 0.942 (throughout gestation) and 0.924 (early gestation) for distinguishing PAS from non-PAS. Overall, single cTBs are detected in the majority of pregnant women, with a detection rate of 98%, 85%, and 86% in the groups of PAS, placenta previa, and normal placentation, respectively.
Margareta D. Pisarska, MD, an Obstetrics and Gynecology Endocrinologist and co-author of the study, said, “In maternal health and delivery, we think of having a child and having a delivery as, overall a happy, healthy event. But in situations like this, these are very difficult times to try to manage through. And if we have a plan in place, schedule the delivery, have the right members on the team on board, have all the things prepared that should lead to a more scheduled controlled delivery.”
The authors concluded that the combination of cTBs and cTB-clusters captured on the NanoVelcro Chips for detecting PAS early in gestation will enable a promising quantitative assay to serve as a noninvasive test and also as a complement to ultrasonography to improve diagnostic accuracy for PAS early in gestation. The study was published on August 3, 2021 in the journal Nature Communications.
Related Links:
Nikon
University of California, Los Angeles
Current diagnostic modalities for PAS, including serum analytes, ultrasonography, and magnetic resonance imaging (MRI), are effective but not always conclusive, and some options are not readily available in low resource settings. Circulating trophoblast cell clusters can be used for early detection of PAS disorders.
Medical Scientists at the University of California, Los Angeles (UCLA, Los Angeles, CA, USA) and their colleagues included in a study pregnant women aged from 18 to 45 years old with singleton intrauterine pregnancies, and gestational age (GA) between 6 and 40 weeks. The team analyzed blood samples from 168 pregnant individuals, divided between those with clinically confirmed PAS, placenta previa, or normal placentation and an additional 15 healthy non-pregnant female donors served as controls.
The investigators used the a cell isolation technology called NanoVelcro Chip developed by UCLA. NanoVelcro is a nanostructure-embedded microchip designed to capture and enrich specific target cells from a mixed sample. The samples were run through NanoVelcro Chips under optimized conditions and immunostained and were imaged using the Nikon Ni fluorescence microscope (Melville, NY, USA). Trophoblast-specific gene expression in placenta tissue was performed to validate the selected trophoblast-specific gene panel.
The team discovered a uniquely high prevalence of clustered circulating trophoblasts (cTB-clusters) in PAS and subsequently optimized the device to preserve the intactness of these clusters. The feasibility study on the enumeration of cTBs and cTB-clusters from 168 pregnant women demonstrates excellent diagnostic performance for distinguishing PAS from non-PAS. The combined cTB assay achieves an Area Under ROC Curve of 0.942 (throughout gestation) and 0.924 (early gestation) for distinguishing PAS from non-PAS. Overall, single cTBs are detected in the majority of pregnant women, with a detection rate of 98%, 85%, and 86% in the groups of PAS, placenta previa, and normal placentation, respectively.
Margareta D. Pisarska, MD, an Obstetrics and Gynecology Endocrinologist and co-author of the study, said, “In maternal health and delivery, we think of having a child and having a delivery as, overall a happy, healthy event. But in situations like this, these are very difficult times to try to manage through. And if we have a plan in place, schedule the delivery, have the right members on the team on board, have all the things prepared that should lead to a more scheduled controlled delivery.”
The authors concluded that the combination of cTBs and cTB-clusters captured on the NanoVelcro Chips for detecting PAS early in gestation will enable a promising quantitative assay to serve as a noninvasive test and also as a complement to ultrasonography to improve diagnostic accuracy for PAS early in gestation. The study was published on August 3, 2021 in the journal Nature Communications.
Related Links:
Nikon
University of California, Los Angeles
Latest Technology News
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
- Paper-Based Biosensor System to Detect Glucose Using Sweat Could Revolutionize Diabetes Management
- First AI-Powered Blood Test Identifies Patients in Earliest Stage of Breast Cancer
- Optical Biosensor Rapidly Detects Monkeypox Virus at Point of Care
- Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients
- New Noninvasive Methods Detect Lead Exposure Faster, Easier and More Accurately at POC
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
Simple DNA PCR-Based Lab Test to Enable Personalized Treatment of Bacterial Vaginosis
Approximately one in three women aged 14-49 in the United States will experience bacterial vaginosis (BV), a vaginal bacterial imbalance, at some point in their lives. Around 50% of BV cases do not present... Read more
Rapid Diagnostic Test to Halt Mother-To-Child Hepatitis B Transmission
Hepatitis B, an inflammation of the liver caused by the hepatitis B virus (HBV), is the second-leading infectious cause of death globally, following tuberculosis. This viral infection can result in serious... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read moreCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read moreInnovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read moreTechnology
view channel
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
Royal Philips (Amsterdam, The Netherlands) has expanded its partnership with Ibex Medical Analytics (Tel Aviv, Israel) and released the new Philips IntelliSite Pathology Solution (PIPS) to further accelerate... Read more
Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
Grifols (Barcelona, Spain), a manufacturer of plasma-derived medicines and innovative diagnostic solutions, has entered into a strategic agreement with Inpeco (Novazzano, Switzerland), a global leader... Read more